Under the current circumstances where medical reform is continuously deepening, the reform of medical insurance payment methods (DRG/DIP) is being fully advanced, and hospital operations are increasingly emphasizing "improving quality, increasing efficiency, and controlling costs," the procurement logic of medical institutions for core medical consumables such as Veress pneumoperitoneum needles is undergoing a fundamental transformation. The simple low-price competition has given way to comprehensive value considerations of quality reliability, long-term cost-effectiveness, full traceability, supply chain stability, and technical service support. Under this trend, bypassing the traditional lengthy and multi-level distribution chain and establishing direct and stable strategic centralized procurement cooperation with the source manufacturers of Veress pneumoperitoneum needles, which have complete qualifications, is becoming the optimal path for all levels of medical institutions to achieve a win-win situation in terms of medical safety, operational efficiency, and economic benefits.

Direct Supply from the Source: Ensure Consistent Quality and Establish a Solid Safety Foundation for Clinical Use

In the traditional distribution model, products go through multiple levels of circulation, making it difficult for medical institutions to conduct effective audits and quality control on the production source. However, the direct source model has established a point-to-point transparent link between "manufacturer and medical institution." This means:

• Controllable quality source: Hospitals can directly review the manufacturer's qualification system (ISO 13485, GMP), production environment, and quality control processes. This ensures that the products meet the highest standards from the very beginning.
• Batch stability guarantee: Products are continuously supplied by the same manufacturer using the same production system, which significantly ensures the high consistency in size, performance, and feel across different batches. This is crucial for surgical operations that rely on muscle memory and stable feel, avoiding potential surgical risks caused by differences in equipment.
• Rapid problem traceability and response: In case of any clinical feedback or adverse events, the specific production batch and even the production process can be quickly located through a direct channel. This enables precise analysis of the problem and closed-loop correction, with response speed far exceeding the traditional model.

Reduce Supply Chain Costs and Achieve Genuine "Cost Reduction and Efficiency Improvement"

In the traditional model, each level of distributor bears the costs of logistics, warehousing, credit period, promotion, and service. These costs will eventually be added to the hospital's purchase price. The direct supply model, through the flattening of the supply chain, has created significant cost reduction opportunities:

• Eliminate intermediate markup: Products are directly shipped from the factory to the hospital's central warehouse or third-party logistics warehouse, eliminating all intermediate agency fees.
• Optimize inventory and logistics: Based on the actual usage data of the hospital, manufacturers can assist in more accurate demand forecasting and inventory management (such as VMI - Vendor Managed Inventory), achieving frequent and small-batch precise replenishment, reducing hospital inventory capital occupation and warehousing management costs.
• Benefits of large-scale centralized procurement: For annual centralized procurement contracts, source manufacturers can offer more competitive step prices. The cost savings are real supply chain optimization gains, not at the expense of product quality.

Provide Full-Process Compliance Support and Professional Technical Services

The value of the original manufacturer goes beyond the product itself; it lies in the additional services they provide:

• Complete compliance file package: Along with the goods, complete registration certificates, production licenses, material reports, biocompatibility reports, sterilization reports, etc. are provided, and they comply with UDI coding requirements, significantly simplifying the administrative work of hospital consumables warehousing, qualification review, and medical insurance integration.
• Clinical technical support: Product usage training can be provided, as well as guidance on compatibility with different brand pneumoperitoneum machine equipment, and even participation in the formulation of surgical room standard operating procedures (SOP).
• Agile supply chain guarantee: For centralized procurement customers, they usually enjoy privileges such as priority production scheduling and a fast track for emergency orders, ensuring uninterrupted clinical supply.

Conclusion

Therefore, choosing the direct supply of Veress pneumoperitoneum needles represents an upgrade in procurement strategy. It enables medical institutions to free up their limited resources from dealing with complex supplier management and quality uncertainties, and instead focus on their core clinical diagnosis and treatment services. The "cost reduction" achieved by it is a value-based reduction based on quality assurance, efficiency improvement, and risk reduction. In today's era where medical consumable management becomes increasingly refined and standardized, establishing a long-term, stable, and transparent strategic partnership with a reliable source manufacturer is undoubtedly a wise choice for all levels of medical institutions to address future challenges and achieve high-quality development.